Alerts will be sent to your verified email
Verify EmailPOSITRON
|
Positron Energy
|
Lahoti Overseas
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
28.49 % | 8.88 % | 28.02 % |
|
5yr average Equity Multiplier
|
2.58 | 1.29 | 1.4 |
|
5yr Average Asset Turnover Ratio
|
2.01 | 2.4 | 1.43 |
|
5yr Avg Net Profit Margin
|
5.86 % | 2.99 % | 11.03 % |
|
Price to Book
|
0.0 | 0.59 | 0.53 |
|
P/E
|
6.56 | 8.94 | 92.22 |
|
5yr Avg Cash Conversion Cycle
|
12.01 Days | 77.52 Days | 154.28 Days |
|
Inventory Days
|
14.67 Days | 8.21 Days | 87.41 Days |
|
Days Receivable
|
25.28 Days | 73.22 Days | 103.86 Days |
|
Days Payable
|
26.53 Days | 2.77 Days | 63.18 Days |
|
5yr Average Interest Coverage Ratio
|
12.35 | 9.7 | 57.05 |
|
5yr Avg ROCE
|
25.69 % | 13.41 % | 36.52 % |
|
5yr Avg Operating Profit Margin
|
7.82 % | 3.64 % | 16.64 % |
|
5 yr average Debt to Equity
|
0.7 | 0.18 | 0.09 |
|
5yr CAGR Net Profit
|
138.58 % | 7.29 % | -5.76 % |
|
5yr Average Return on Assets
|
11.43 % | 6.79 % | 18.47 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.2 % | 59.81 % | 65.99 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.2 % | 0.0 | -5.58 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Positron Energy
|
Lahoti Overseas
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|